[1]陈 伟.硼替佐米诱发急性肺损伤1例并文献复习[J].医学信息,2018,31(22):191-192.[doi:10.3969/j.issn.1006-1959.2018.22.058]
点击复制

硼替佐米诱发急性肺损伤1例并文献复习()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年22期
页码:
191-192
栏目:
出版日期:
2018-11-15

文章信息/Info

文章编号:
1006-1959（2018）22-0190-02
作者:
陈 伟
（徐州医科大学附属医院血液科，江苏 徐州 221000）
分类号:
R733.3
DOI:
10.3969/j.issn.1006-1959.2018.22.058
文献标志码:
B

参考文献/References:


[1]Terpos E, Katodritou E, Delarubia J,et al.Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice[J].Eur J Haematol,2018.
[2]Rajan AM,Rajkumar SV.Treatment of newly diagnosed myeloma: Bortezomib-based triplet[J].Semin Oncol,2016,43(6):700-702.
[3]陈伟,孔庆玲,曹江,等.硼替佐米致多发性骨髓瘤患者急性肺损伤的临床特征、诊断及治疗[J].徐州医学院学报,2015(11):741-744.
[4]Miyakoshi S,Kami M,Yuji K,et al.Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma[J].Blood,2006,107(9):3492-3494.
[5]顿晓熠,袁振刚,傅卫军,等.硼替佐米治疗多发性骨髓瘤致五例患者严重肺损伤[J].中华血液学杂志,2010,31(4):259-261.
[6]王亚飞,邱录贵,邹德慧,等.硼替佐米治疗多发性骨髓瘤后严重肺损伤二例报告并文献复习[J].白血病淋巴瘤,2008,17(2):100-102.
[7]Boyer JE,Batra RB,Ascensao JL,et al.Severe pulmonary complication after bortezomib treatment for multiple myeloma[J].Blood,2006,108(3):1113.
[8]Dimopoulos MA,Goldschmidt H,Niesvizky R,et al.Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial[J].Lancet Oncol,2017,18(10):1327-1337.

更新日期/Last Update: 2018-12-03